Anti-Infective Agents
Research News and Information

Monday, November 23, 2009

Budd-Chiari syndrome as a vascular complication of amebic liver abscess.

30 Oct 2009 Amebiasis remains a major public health issue in most of the world. Amebic liver abscess is the most common extraintestinal manifestation. A complication such as venous obstruction associated with amebiais is rare. We report a thrombosis in hepatic ... Read more...

Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia.

16 Oct 2009 BACKGROUND: Pneumocystis jirovecii, formerly named Pneumocystis carinii, is one of the most common opportunistic infections in human immunodeficiency virus (HIV)-infected patients. CASE PRESENTATIONS: We encountered two cases of spontaneous ... Read more...

Human health consequences of use of antimicrobial agents in aquaculture.

13 Oct 2009 Intensive use of antimicrobial agents in aquaculture provides a selective pressure creating reservoirs of drug-resistant bacteria and transferable resistance genes in fish pathogens and other bacteria in the aquatic environment. From these ... Read more...

Latest indexed articles for 'Anti-Infective Agents'

These are the very latest articles for this heading:

• Microbicide development: positive women's concerns. 29 Nov 2009
• Contact lens solutions: part of the problem. 30 Oct 2009
• Positive aspects of the use of multipurpose disinfection solutions. 30 Oct 2009
• Budd-Chiari syndrome as a vascular complication of amebic liver abscess. 30 Oct 2009
• Some unanswered questions about temperature management. 30 Oct 2009
• Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia. 16 Oct 2009
• Human health consequences of use of antimicrobial agents in aquaculture. 13 Oct 2009
• Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania. 7 Oct 2009
• Significant publications on infectious diseases pharmacotherapy in 2008. 29 Sep 2009
• Physician's practice patterns for chronic prostatitis. 29 Sep 2009
• A phase II randomized controlled trial to evaluate the safety and efficacy of Praneem polyherbal vaginal tablets compared with betadine vaginal pessary in women with symptoms of abnormal vaginal discharge. 29 Sep 2009
• Clinical and tomographic features of macular punctate outer retinal toxoplasmosis. 29 Sep 2009
• Micro-organism and cell viability on antimicrobially modified titanium. 29 Sep 2009
• Periodontal therapy improves gastric Helicobacter pylori eradication. 29 Sep 2009
• One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus. 29 Sep 2009
• Single immunoglobulin infusion can reverse hemodynamic failure associated with severe Clostridium difficile colitis. 29 Sep 2009
• Tegumentary leishmaniasis as the cause of immune reconstitution inflammatory syndrome in a patient co-infected with human immunodeficiency virus and Leishmania guyanensis. 29 Sep 2009
• Co-Infection of Leishmania (Viannia) braziliensis and HIV: report of a case of mucosal leishmaniasis in Cochabamba, Bolivia. 29 Sep 2009
• Effect of multiple- and single-day enrofloxacin medications against dual experimental infection with avian pneumovirus and Escherichia coli in turkeys. 29 Sep 2009
• Nitric oxide-containing nanoparticles as an antimicrobial agent and enhancer of wound healing. 29 Sep 2009

See a longer list of these articles.

Technical information about 'Anti-Infective Agents'

Definition: Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.

Registry Number: 0

Descriptor UI: D000890

Alternative terms: Anti-Infective Agents; Agents, Anti-Infective; Anti Infective Agents; Antiinfective Agents; Agents, Antiinfective; Microbicides; Antimicrobial Agents; Agents, Antimicrobial; Anti-Microbial Agents; Agents, Anti-Microbial; Anti Microbial Agents;

Related Mesh Headings: Anthelmintics; Antiprotozoal Agents;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.122;

Technical Notes: general or unspecified; prefer specific groups